Clinically relevant results from cardiovascular outcome trials
Crossref DOI link: https://doi.org/10.1038/nrendo.2017.179
Published Online: 2018-01-05
Published Print: 2018-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Holman, Rury R.
Text and Data Mining valid from 2018-01-05
Article History
First Online: 5 January 2018
Competing interests
: R.R.H. has received grants and personal fees from Bayer AG relating to the ACE study and personal fees from Novartis.